Patents by Inventor Robin Carr

Robin Carr has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Imidazo[1,2-a]pyridine compounds and their use in therapy
    Patent number: 12637458
    Abstract: The invention relates to compounds of Formula (I): and related aspects.
    Type: Grant
    Filed: September 17, 2021
    Date of Patent: May 26, 2026
    Assignees: IMPERIAL COLLEGE INNOVATIONS LIMITED, MYRICX PHARMA LIMITED
    Inventors: Edward William Tate, Andrew Simon Bell, Roger Bonnert, Robin Carr, Timothy John Ritchie
  • Cytotoxic imidazo[1,2-A]pyridine compounds and their use in therapy
    Patent number: 12599676
    Abstract: The present invention relates to compounds of formula (I) and related aspects.
    Type: Grant
    Filed: March 6, 2025
    Date of Patent: April 14, 2026
    Assignees: MyricX Pharma Limited, Imperial College Innovations Limited
    Inventors: Robin Carr, Roberto Solari, Andrew Simon Bell, Edward William Tate, Roger Bonnert
  • ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR AND ITS USE
    Publication number: 20260083858
    Abstract: The present invention relates to ADCs comprising a NMT inhibitor conjugated to an antibody via a linker, and related uses.
    Type: Application
    Filed: September 8, 2023
    Publication date: March 26, 2026
    Inventors: Robin CARR, Roberto SOLARI, Edward William TATE, Andrew Simon BELL, Roger BONNERT
  • CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
    Publication number: 20260049075
    Abstract: The present invention relates to compounds of formula (I) and related aspects.
    Type: Application
    Filed: March 6, 2025
    Publication date: February 19, 2026
    Inventors: Robin CARR, Roberto SOLARI, Andrew Simon BELL, Edward William TATE, Roger BONNERT
  • CYTOTOXIC IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
    Publication number: 20260048136
    Abstract: The present invention relates to compounds of formula (1) and related aspects.
    Type: Application
    Filed: March 6, 2025
    Publication date: February 19, 2026
    Inventors: Robin CARR, Roberto SOLARI, Andrew Simon BELL, Edward William TATE, Roger BONNERT
  • IMIDAZO[1,2-A]PYRIDINE COMPOUNDS AND THEIR USE IN THERAPY
    Publication number: 20240166643
    Abstract: The invention relates to compounds of Formula (I): and related aspects.
    Type: Application
    Filed: September 17, 2021
    Publication date: May 23, 2024
    Applicants: Imperial College Innovations Limited, MyricX Pharma Limited
    Inventors: Edward William TATE, Andrew Simon BELL, Roger BONNERT, Robin CARR, Timothy John RITCHIE
  • Pharmaceutical compounds
    Publication number: 20070129281
    Abstract: The invention provides novel inhibitors of protein tyrosine phosphatase sulfenyl amide and their use in medicine, for example in the treatment or prevention of disease states such as cancer, diabetes, rheumatoid arthritis and hypertension. Also provided are novel crystal structures and the use of the crystal structures and their X-ray coordinates in the development of new drugs.
    Type: Application
    Filed: April 1, 2004
    Publication date: June 7, 2007
    Inventors: Robin Carr, Miles Congreve, Dominic Tisi, Robert Leon Van Montfort, Nicola Wallis, Glyn Williams, Harren Jhoti